Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gemma N. Jones
pRAD50: A Novel and Clinically Applicable Pharmacodynamic Biomarker of Both ATM and ATR Inhibition Identified Using Mass Spectrometry and Immunohistochemistry
British Journal of Cancer
Cancer Research
Oncology
The Novel ATM Inhibitor (AZ31) Enhances Antitumor Activity in Patient Derived Xenografts That Are Resistant to Irinotecan Monotherapy
Oncotarget
Oncology
Related publications
From Biomarker Discovery to Proteomic Validation Using Mass Spectrometry
Acta Ophthalmologica
Medicine
Ophthalmology
Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells
Cancers
Cancer Research
Oncology
Measurement of Cyclooxygenase Inhibition Using Liquid Chromatography–tandem Mass Spectrometry
Journal of Pharmaceutical and Biomedical Analysis
Clinical Biochemistry
Drug Discovery
Analytical Chemistry
Spectroscopy
Pharmaceutical Science
Rapid Activation of ATR by Ionizing Radiation Requires ATM and Mre11
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Cell Cycle Checkpoint Signaling Through the ATM and ATR Kinases
Genes and Development
Genetics
Developmental Biology
Twelve Novel Atm Mutations Identified in Chinese Ataxia Telangiectasia Patients
NeuroMolecular Medicine
Molecular Neuroscience
Neurology
Molecular Medicine
Cellular
Straightforward and Highly Efficient Strategy for Hepatocellular Carcinoma Glycoprotein Biomarker Discovery Using a Nonglycopeptide-Based Mass Spectrometry Pipeline
Structural Characterization of Anticancer Drug Paclitaxel and Its Metabolites Using Ion Mobility Mass Spectrometry and Tandem Mass Spectrometry
Journal of the American Society for Mass Spectrometry
Structural Biology
Spectroscopy
Clinically Applicable Deep Learning Algorithm Using Quantitative Proteomic Data
